Sirtuin 1 and endothelial glycocalyx
暂无分享,去创建一个
[1] T. Rabelink,et al. Endothelial glycocalyx hyaluronan: regulation and role in prevention of diabetic complications. , 2020, The American journal of pathology.
[2] B. Flamion,et al. Endothelial glycocalyx impairment in disease: Focus on hyaluronan shedding. , 2020, The American journal of pathology.
[3] M. Goligorsky,et al. GLYCOCALYX IN ENDOTOXEMIA AND SEPSIS. , 2020, The American journal of pathology.
[4] Y. Cho,et al. Tissue-resident natural killer cells exacerbate tubulointerstitial fibrosis by activating transglutaminase 2 and syndecan-4 in a model of aristolochic acid-induced nephropathy , 2019, BMB reports.
[5] T. Jenssen,et al. Matrix metalloproteinase‐9 mediated shedding of syndecan‐4 in glomerular endothelial cells , 2019, Microcirculation.
[6] J. Tarbell,et al. Endothelial surface glycocalyx (ESG) components and ultra-structure revealed by stochastic optical reconstruction microscopy (STORM). , 2019, Biorheology.
[7] H. Dihazi,et al. Dickkopf-3 in aberrant endothelial secretome triggers renal fibroblast activation and endothelial–mesenchymal transition , 2019, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[8] G. Gambaro,et al. Inhibition of heparanase protects against chronic kidney dysfunction following ischemia/reperfusion injury , 2018, Oncotarget.
[9] M. Goligorsky,et al. Endothelial cell dysfunction and glycocalyx - A vicious circle. , 2018, Matrix biology : journal of the International Society for Matrix Biology.
[10] H. Dihazi,et al. Fibrogenic Secretome of Sirtuin 1-Deficient Endothelial Cells: Wnt, Notch and Glycocalyx Rheostat , 2018, Front. Physiol..
[11] H. Dihazi,et al. Endothelial dysfunction is a superinducer of syndecan-4: fibrogenic role of its ectodomain. , 2018, American journal of physiology. Heart and circulatory physiology.
[12] M. Goligorsky,et al. Endothelial glycocalyx—the battleground for complications of sepsis and kidney injury , 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[13] H. Dihazi,et al. The third path of tubulointerstitial fibrosis: aberrant endothelial secretome. , 2017, Kidney international.
[14] D. Liveris,et al. Therapeutic Restoration of Endothelial Glycocalyx in Sepsis , 2017, The Journal of Pharmacology and Experimental Therapeutics.
[15] A. Lupo,et al. Involvement of heparanase in the pathogenesis of acute kidney injury: nephroprotective effect of PG545 , 2017, Oncotarget.
[16] R. Sanderson,et al. Heparanase regulation of cancer, autophagy and inflammation: new mechanisms and targets for therapy , 2017, The FEBS journal.
[17] G. Gambaro,et al. Heparanase: A Potential New Factor Involved in the Renal Epithelial Mesenchymal Transition (EMT) Induced by Ischemia/Reperfusion (I/R) Injury , 2016, PloS one.
[18] G. Christensen,et al. Syndecans in heart fibrosis , 2016, Cell and Tissue Research.
[19] M. Götte,et al. Shed proteoglycans in tumor stroma , 2016, Cell and Tissue Research.
[20] E. Pasini,et al. Endothelial Glycocalyx: Shedding Light on Malaria Pathogenesis. , 2016, Trends in molecular medicine.
[21] M. Goligorsky,et al. Sirtuins, Cell Senescence, and Vascular Aging. , 2016, The Canadian journal of cardiology.
[22] T. Rabelink,et al. Heparanase Is Essential for the Development of Acute Experimental Glomerulonephritis. , 2016, The American journal of pathology.
[23] T. Rabelink,et al. Endothelin-1 Induces Proteinuria by Heparanase-Mediated Disruption of the Glomerular Glycocalyx. , 2016, Journal of the American Society of Nephrology : JASN.
[24] M. Goligorsky,et al. Mechanotransduction of the endothelial glycocalyx mediates nitric oxide production through activation of TRP channels. , 2016, American journal of physiology. Cell physiology.
[25] J. Tarbell,et al. EXOCYTOSIS OF ENDOTHELIAL LYSOSOME‐RELATED ORGANELLES HAIR‐TRIGGERS A PATCHY LOSS OF GLYCOCALYX AT THE ONSET OF SEPSIS , 2016, The American journal of pathology.
[26] W. Pan,et al. Resveratrol Protects against TNF-α-Induced Injury in Human Umbilical Endothelial Cells through Promoting Sirtuin-1-Induced Repression of NF-KB and p38 MAPK , 2016, PloS one.
[27] I. Sjaastad,et al. Shedding of syndecan-4 promotes immune cell recruitment and mitigates cardiac dysfunction after lipopolysaccharide challenge in mice. , 2015, Journal of molecular and cellular cardiology.
[28] L. Guarente,et al. The multifaceted functions of sirtuins in cancer , 2015, Nature Reviews Cancer.
[29] M. Jacob,et al. Degradation of the endothelial glycocalyx in clinical settings: searching for the sheddases , 2015, British journal of clinical pharmacology.
[30] H. Vink,et al. Perturbed mechanotransduction by endothelial surface glycocalyx modification greatly impairs the arteriogenic process. , 2015, American journal of physiology. Heart and circulatory physiology.
[31] G. Gambaro,et al. Impact of heparanase on renal fibrosis , 2015, Journal of Translational Medicine.
[32] J. Holcomb,et al. Endothelial glycocalyx shedding and vascular permeability in severely injured trauma patients , 2015, Journal of Translational Medicine.
[33] T. Jenssen,et al. Syndecan-4 Is a Major Syndecan in Primary Human Endothelial Cells In Vitro, Modulated by Inflammatory Stimuli and Involved in Wound Healing , 2015, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[34] M. Goligorsky,et al. Sirtuin 1 ablation in endothelial cells is associated with impaired angiogenesis and diastolic dysfunction. , 2014, American journal of physiology. Heart and circulatory physiology.
[35] R. Foster,et al. Matrix metalloproteinase 9‐mediated shedding of syndecan 4 in response to tumor necrosis factor α: a contributor to endothelial cell glycocalyx dysfunction , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[36] M. Vogeser,et al. Hypervolemia increases release of atrial natriuretic peptide and shedding of the endothelial glycocalyx , 2014, Critical Care.
[37] S. Kersten. Physiological regulation of lipoprotein lipase. , 2014, Biochimica et biophysica acta.
[38] B. Brenner,et al. Heparanase multiple effects in cancer. , 2014, Thrombosis research.
[39] Linghong Huang,et al. Syndecan-4 knockout leads to reduced extracellular transglutaminase-2 and protects against tubulointerstitial fibrosis. , 2014, Journal of the American Society of Nephrology : JASN.
[40] R. R. Domingues,et al. Deciphering the role of the ADAM17-dependent secretome in cell signaling. , 2014, Journal of proteome research.
[41] M. Goligorsky,et al. Endothelial sirtuin 1 deficiency perpetrates nephrosclerosis through downregulation of matrix metalloproteinase-14: relevance to fibrosis of vascular senescence. , 2014, Journal of the American Society of Nephrology : JASN.
[42] J. Tarbell,et al. Sphingosine-1-phosphate protects endothelial glycocalyx by inhibiting syndecan-1 shedding. , 2014, American journal of physiology. Heart and circulatory physiology.
[43] T. Rabelink,et al. The role of heparanase and the endothelial glycocalyx in the development of proteinuria. , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[44] M. Simpson,et al. Emerging roles for hyaluronidase in cancer metastasis and therapy. , 2014, Advances in cancer research.
[45] W. Sessa,et al. Angiopoietin-2 Secretion by Endothelial Cell Exosomes , 2013, The Journal of Biological Chemistry.
[46] T. Suuronen,et al. Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders. , 2013, Cellular signalling.
[47] T. Rabelink,et al. The endothelial glycocalyx as a potential modifier of the hemolytic uremic syndrome. , 2013, European journal of internal medicine.
[48] D. Vynios,et al. Hyaluronidases and their inhibitors in the serum of colorectal carcinoma patients. , 2013, Journal of pharmaceutical and biomedical analysis.
[49] M. Simons,et al. Syndecan-4 signaling at a glance , 2013, Journal of Cell Science.
[50] R. Goldberg,et al. Versatile role of heparanase in inflammation. , 2013, Matrix biology : journal of the International Society for Matrix Biology.
[51] J. Li,et al. Antithrombin is protective against myocardial ischemia and reperfusion injury , 2013, Journal of thrombosis and haemostasis : JTH.
[52] John M Tarbell,et al. Mechano‐sensing and transduction by endothelial surface glycocalyx: composition, structure, and function , 2013, Wiley interdisciplinary reviews. Systems biology and medicine.
[53] C. Carlson,et al. Innate immune signaling induces expression and shedding of the heparan sulfate proteoglycan syndecan‐4 in cardiac fibroblasts and myocytes, affecting inflammation in the pressure‐overloaded heart , 2013, The FEBS journal.
[54] Li Zhang,et al. Negative regulation of inflammation by SIRT1. , 2013, Pharmacological research.
[55] A. Thotakura,et al. The nuclear factor kappa B signaling pathway: integrating metabolism with inflammation. , 2012, Trends in cell biology.
[56] D. Spillmann,et al. The Mutual Impact of Syndecan-1 and Its Glycosaminoglycan Chains—A Multivariable Puzzle , 2012, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[57] Yimu Yang,et al. The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis , 2012, Nature Medicine.
[58] Johan Auwerx,et al. Sirtuins as regulators of metabolism and healthspan , 2012, Nature Reviews Molecular Cell Biology.
[59] Jin-ping Li,et al. Heparanase overexpression reduces carrageenan-induced mechanical and cold hypersensitivity in mice , 2012, Neuroscience Letters.
[60] M. Goligorsky,et al. Cathepsin cleavage of sirtuin 1 in endothelial progenitor cells mediates stress-induced premature senescence. , 2012, The American journal of pathology.
[61] P. Park,et al. Molecular functions of syndecan-1 in disease. , 2012, Matrix biology : journal of the International Society for Matrix Biology.
[62] T. Annecke,et al. Shedding of the coronary endothelial glycocalyx: effects of hypoxia/reoxygenation vs ischaemia/reperfusion. , 2011, British journal of anaesthesia.
[63] J. Esko,et al. Heparan sulfate proteoglycans. , 2011, Cold Spring Harbor perspectives in biology.
[64] Ashraf A Bakkar,et al. Targeting hyaluronidase for cancer therapy: antitumor activity of sulfated hyaluronic acid in prostate cancer cells. , 2011, Cancer research.
[65] L. Guarente. Franklin H. Epstein Lecture: Sirtuins, aging, and medicine. , 2011, The New England journal of medicine.
[66] Y. Matsui,et al. Syndecan-4 Prevents Cardiac Rupture and Dysfunction After Myocardial Infarction , 2011, Circulation research.
[67] T. Peretz,et al. Heparanase powers a chronic inflammatory circuit that promotes colitis-associated tumorigenesis in mice. , 2011, The Journal of clinical investigation.
[68] H. Lipowsky. Protease Activity and the Role of the Endothelial Glycocalyx in Inflammation. , 2011, Drug discovery today. Disease models.
[69] M. Christiaans,et al. Acute ischemic injury to the renal microvasculature in human kidney transplantation. , 2010, American journal of physiology. Renal physiology.
[70] J. Couchman,et al. Transmembrane signaling proteoglycans. , 2010, Annual review of cell and developmental biology.
[71] M. Jacob,et al. Endothelial glycocalyx and coronary vascular permeability: the fringe benefit , 2010, Basic Research in Cardiology.
[72] M. Gooz. ADAM-17: the enzyme that does it all , 2010, Critical reviews in biochemistry and molecular biology.
[73] M. Swellam,et al. Expression of HYAL1 and survivin RNA as diagnostic molecular markers for bladder cancer. , 2010, The Journal of urology.
[74] Vasilis Vasiliou,et al. Evolutionary divergence and functions of the ADAM and ADAMTS gene families , 2009, Human Genomics.
[75] H. van Goor,et al. ADAM17 upregulation in human renal disease: a role in modulating TGF-alpha availability? , 2009, American journal of physiology. Renal physiology.
[76] U. Welsch,et al. Antithrombin reduces shedding of the endothelial glycocalyx following ischaemia/reperfusion. , 2009, Cardiovascular research.
[77] Michiyuki Matsuda,et al. Suppression of RhoG activity is mediated by a syndecan 4–synectin–RhoGDI1 complex and is reversed by PKCα in a Rac1 activation pathway , 2009, The Journal of cell biology.
[78] B. Walcheck,et al. Regulation of Mature ADAM17 by Redox Agents for L-Selectin Shedding1 , 2009, The Journal of Immunology.
[79] E. Edelman,et al. Heparanase Alters Arterial Structure, Mechanics, and Repair Following Endovascular Stenting in Mice , 2009, Circulation research.
[80] G. Wong,et al. Hyaluronan-mediated CD44 Interaction with p300 and SIRT1 Regulates β-Catenin Signaling and NFκB-specific Transcription Activity Leading to MDR1 and Bcl-xL Gene Expression and Chemoresistance in Breast Tumor Cells* , 2009, Journal of Biological Chemistry.
[81] Paul N. Smith,et al. Dramatic regulation of heparanase activity and angiogenesis gene expression in synovium from patients with rheumatoid arthritis. , 2008, Arthritis and rheumatism.
[82] N. J. Nasser. Heparanase involvement in physiology and disease , 2008, Cellular and Molecular Life Sciences.
[83] I. Poola,et al. Molecular Risk Assessment for Breast Cancer Development in Patients with Ductal Hyperplasias , 2008, Clinical Cancer Research.
[84] F. Alt,et al. SIRT1 controls endothelial angiogenic functions during vascular growth. , 2007, Genes & development.
[85] Francis G Spinale,et al. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. , 2007, Physiological reviews.
[86] J. Kastelein,et al. Perturbation of hyaluronan metabolism predisposes patients with type 1 diabetes mellitus to atherosclerosis , 2007, Diabetologia.
[87] C. Hansch,et al. Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs. , 2007, Bioorganic & medicinal chemistry.
[88] Dick W. Slaaf,et al. The endothelial glycocalyx: composition, functions, and visualization , 2007, Pflügers Archiv - European Journal of Physiology.
[89] P. Raynaud,et al. Heparanase influences expression and shedding of syndecan-1, and its expression by the bone marrow environment is a bad prognostic factor in multiple myeloma. , 2006, Blood.
[90] A. Brasier. The NF-κB regulatory network , 2007, Cardiovascular Toxicology.
[91] M. Sperandio. Selectins and glycosyltransferases in leukocyte rolling in vivo , 2006, The FEBS journal.
[92] T. Peretz,et al. Role of endothelial heparanase in delayed-type hypersensitivity. , 2006, Blood.
[93] R. Heine,et al. Endothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetes. , 2006, Diabetes.
[94] A. Brasier. The NF-kappaB regulatory network. , 2006, Cardiovascular toxicology.
[95] Hans Vink,et al. The endothelial glycocalyx: a potential barrier between health and vascular disease , 2005, Current opinion in lipidology.
[96] P. E. Van den Steen,et al. Targeting neutrophil collagenase/matrix metalloproteinase-8 and gelatinase B/matrix metalloproteinase-9 with a peptidomimetic inhibitor protects against endotoxin shock. , 2005, Biochemical pharmacology.
[97] Satoshi O. Suzuki,et al. Clinical Significance of Heparin-Binding Epidermal Growth Factor–Like Growth Factor and A Disintegrin and Metalloprotease 17 Expression in Human Ovarian Cancer , 2005, Clinical Cancer Research.
[98] M. Kawaguchi,et al. Overexpression of tumour necrosis factor‐α‐converting enzyme in psoriasis , 2005 .
[99] J. Platt,et al. Conditional signaling by Toll‐like receptor 4 , 2005, The FASEB Journal.
[100] E. Tkachenko,et al. Syndecans: new kids on the signaling block. , 2005, Circulation research.
[101] M. Mayo,et al. Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase , 2004, The EMBO journal.
[102] M. Karin,et al. The two NF-κB activation pathways and their role in innate and adaptive immunity , 2004 .
[103] Guangping Chen,et al. Inflammatory cytokines and fatty acids regulate endothelial cell heparanase expression. , 2004, Biochemistry.
[104] Steven P. Gygi,et al. Stress-Dependent Regulation of FOXO Transcription Factors by the SIRT1 Deacetylase , 2004, Science.
[105] Delin Chen,et al. Mammalian SIRT1 Represses Forkhead Transcription Factors , 2004, Cell.
[106] A. Mulivor,et al. Inflammation- and ischemia-induced shedding of venular glycocalyx. , 2004, American journal of physiology. Heart and circulatory physiology.
[107] M. Karin,et al. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. , 2004, Trends in immunology.
[108] F. Zhan,et al. High heparanase activity in multiple myeloma is associated with elevated microvessel density. , 2003, Cancer research.
[109] J. Couchman. Syndecans: proteoglycan regulators of cell-surface microdomains? , 2003, Nature Reviews Molecular Cell Biology.
[110] Jeffry A Florian,et al. Heparan Sulfate Proteoglycan Is a Mechanosensor on Endothelial Cells , 2003, Circulation research.
[111] T. Yoshizaki,et al. Cleavage of Syndecan-1 by Membrane Type Matrix Metalloproteinase-1 Stimulates Cell Migration* , 2003, Journal of Biological Chemistry.
[112] B. Duling,et al. Rapid modification of the glycocalyx caused by ischemia-reperfusion is inhibited by adenosine A2A receptor activation. , 2003, American journal of physiology. Heart and circulatory physiology.
[113] J. Baselga,et al. TACE is required for the activation of the EGFR by TGF‐α in tumors , 2003 .
[114] J. Baselga,et al. TACE is required for the activation of the EGFR by TGF-alpha in tumors. , 2003, The EMBO journal.
[115] Vincenza Dolo,et al. Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells. , 2002, The American journal of pathology.
[116] K. Shimamoto,et al. Effect of TNF-α–Converting Enzyme Inhibitor on Insulin Resistance in Fructose-Fed Rats , 2002 .
[117] K. Shimamoto,et al. Effect of TNF-alpha--converting enzyme inhibitor on insulin resistance in fructose-fed rats. , 2002, Hypertension.
[118] H. Saito,et al. Syndecan-4 Deficiency Leads to High Mortality of Lipopolysaccharide-injected Mice* , 2001, The Journal of Biological Chemistry.
[119] N. Kamatani,et al. Tumor necrosis factor-alpha (TNF-alpha) converting enzyme contributes to production of TNF-alpha in synovial tissues from patients with rheumatoid arthritis. , 2001, The Journal of rheumatology.
[120] M. Detmar,et al. Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4. , 2001, The Journal of clinical investigation.
[121] Z. Werb,et al. How matrix metalloproteinases regulate cell behavior. , 2001, Annual review of cell and developmental biology.
[122] A. Nandi,et al. Hyaluronan Anchoring and Regulation on the Surface of Vascular Endothelial Cells Is Mediated through the Functionally Active Form of CD44* , 2000, The Journal of Biological Chemistry.
[123] T. W. Secomb,et al. The endothelial surface layer , 2000, Pflügers Archiv.
[124] S. Tumova,et al. Heparan Sulfate Chains from Glypican and Syndecans Bind the Hep II Domain of Fibronectin Similarly Despite Minor Structural Differences* , 2000, The Journal of Biological Chemistry.
[125] B. Duling,et al. Permeation of the luminal capillary glycocalyx is determined by hyaluronan. , 1999, American journal of physiology. Heart and circulatory physiology.
[126] R. Frye,et al. Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity. , 1999, Biochemical and biophysical research communications.
[127] J. Harlan,et al. Adhesion of Activated Platelets to Endothelial Cells: Evidence for a GPIIbIIIa-dependent Bridging Mechanism and Novel Roles for Endothelial Intercellular Adhesion Molecule 1 (ICAM-1), αvβ3 Integrin, and GPIbα , 1998, The Journal of experimental medicine.
[128] G. Ghosh,et al. Crystal structure of p50/p65 heterodimer of transcription factor NF-κB bound to DNA , 1998, Nature.
[129] M J May,et al. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. , 1998, Annual review of immunology.
[130] Klaus Ley,et al. Regulation of E‐Selectin, P‐Selectin, and Intercellular Adhesion Molecule 1 Expression in Mouse Cremaster Muscle Vasculature , 1997, Microcirculation.
[131] H. V. Van Wart,et al. Hydrolysis of a Broad Spectrum of Extracellular Matrix Proteins by Human Macrophage Elastase* , 1997, The Journal of Biological Chemistry.
[132] R. Gallo,et al. Syndecans-1 and -4 are induced during wound repair of neonatal but not fetal skin. , 1996, The Journal of investigative dermatology.
[133] W. Graber,et al. Association of hyaluronan with rat vascular endothelial and smooth muscle cells. , 1995, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[134] B. Feldt-Rasmussen,et al. Effect of low-dose heparin on urinary albumin excretion in insulin-dependent diabetes mellitus , 1995, The Lancet.
[135] Choll W. Kim,et al. Members of the syndecan family of heparan sulfate proteoglycans are expressed in distinct cell-, tissue-, and development-specific patterns. , 1994, Molecular biology of the cell.
[136] B. F. Becker. Towards the physiological function of uric acid. , 1993, Free radical biology & medicine.
[137] M. Laato,et al. Induced expression of syndecan in healing wounds , 1991, The Journal of cell biology.
[138] T. Deckert,et al. Possible Genetic Defects in Regulation of Glycosaminoglycans in Patients With Diabetic Nephropathy , 1991, Diabetes.